Gastroenterologie up2date, Table of Contents Gastroenterologie up2date 2021; 17(03): 218-220DOI: 10.1055/a-1532-9554 Studienreferate Kommentar Recommend Article Abstract Buy Article All articles of this category Comment to this article: Sport plus Liraglutid – die Kombi machtʼsGastroenterologie up2date 2021; 17(03): 216-218DOI: 10.1055/a-1525-3923 Full Text References Literatur 1 Park J, Morley TS, Kim M. et al. Obesity and cancer–mechanisms underlying tumour progression and recurrence. Nat Rev Endocrinol 2014; 10: 455-465 2 Schattenberg JM, Lazarus JV, Newsome PN. et al. Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: A cost-of-illness analysis. Liver Int 2021; 41: 1227-1242 3 Haftenberger M, Mensink GB, Herzog B. et al. Changes in body weight and obesity status in German adults: results of seven population-based prospective studies. Eur J Clin Nutr 2016; 70: 300-305 4 Look ARG, Wing RR, Bolin P. et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 2013; 369: 145-154 5 Lundgren JR, Janus C, Jensen SBK. et al. Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined. N Engl J Med 2021; 384: 1719-1730 6 Newsome PN, Buchholtz K, Cusi K. et al. A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis. N Engl J Med 2021; 384: 1113-1124
